Nektar Therapeutics Share Price (NASDAQ: NKTR)
$29.82
▲
0.48
(1.64%)
Last updated on
Check the interactive Nektar Therapeutics Stock chart to analyse performance
Nektar Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$28.63Today's High:$29.84
3.99%
Downside
Day's Volatility :4.05%
Upside
0.07%
- 52 Weeks Low:$6.4852 Weeks High:$37.38
78.27%
Downside
52 Weeks Volatility :82.66%
Upside
20.22%
Nektar Therapeutics Stock Returns
Nektar Therapeutics Key Stats
Check Nektar Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Nektar Therapeutics Stock including INR - Dollar returns
The Nektar Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Nektar Therapeutics investment value today
Current value as on today
₹1,60,597
Returns
₹60,597
(+60.6%)
Returns from Nektar Therapeutics Stock
₹55,313 (+55.31%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Nektar Therapeutics Stock
Global Institutional Holdings in Nektar Therapeutics
Name
Holdings %
BlackRock Inc
5.85%
Vanguard Group Inc
4.07%
Nantahala Capital Management, LLC
3.96%
Acadian Asset Management LLC
2.72%
Eventide Asset Management, LLC
2.48%
Renaissance Technologies Corp
1.75%
Analyst Recommendation on Nektar Therapeutics Stock
Hold
0%Buy
55%Hold
44%Sell
Based on 9 Wall street analysts offering stock ratings for Nektar Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Nektar Therapeutics Share Price Target
What analysts predicted
Upside of 222.49%
Target:
$96.17
Current:
$29.82
Nektar Therapeutics share price target is $96.17, a slight Upside of 222.49% compared to current price of $29.82 as per analysts' prediction.
Nektar Therapeutics Stock Insights
Price Movement
In the last 7 days, NKTR stock has moved up by 10.3%Increasing Revenue
Revenue is up for the last 2 quarters, 10.46M → 11.17M (in $), with an average increase of 6.4% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -50.88M → -41.59M (in $), with an average increase of 22.3% per quarterNKTR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 14.6%NKTR vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 163.3%Price to Sales
ForNKTR every $1 of sales, investors are willing to pay $5.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Nektar Therapeutics Financials
Nektar Therapeutics Technicals Summary
Sell
Neutral
Buy
Nektar Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Nektar Therapeutics Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 37.52% | 147.87% | 60.3% | -50.56% | -89.62% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 3.22 | -11.06 | -4.41 | -0.32 | NA | -1.94 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Hold | $567.9M | -89.62% | NA | -163.17% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Nektar Therapeutics
Key Management of Nektar Therapeutics
Important FAQs about investing in NKTR Stock from India :
What is Nektar Therapeutics share price today?
Nektar Therapeutics share price today is $29.82 as on at the close of the market. Nektar Therapeutics share today touched a day high of $29.84 and a low of $28.63.
What is the 52 week high and 52 week low for Nektar Therapeutics share?
Nektar Therapeutics share touched a 52 week high of $37.38 and a 52 week low of $6.48. Nektar Therapeutics stock price today i.e. is closed at $29.82, lower by 20.22% versus the 52 week high.
How to invest in Nektar Therapeutics Stock (NKTR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Nektar Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nektar Therapeutics Shares that will get you 0.0503 shares as per Nektar Therapeutics share price of $29.82 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Nektar Therapeutics Stock (NKTR) from India?
Indian investors can start investing in Nektar Therapeutics (NKTR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Nektar Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Nektar Therapeutics share’s latest price of $29.82 as on August 30, 2025 at 1:29 am IST, you will get 0.3353 shares of Nektar Therapeutics. Learn more about
fractional shares .
What are the returns that Nektar Therapeutics has given to Indian investors in the last 5 years?
Nektar Therapeutics stock has given -89.62% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%